Collaborative hub founded by philanthropist Lisa Yang will catalyze academic innovation and result in real-world, global impact.

The COVID-19 pandemic demonstrated the promise of using mRNA as medicine. But before mRNA drugs can go beyond vaccines, researchers need to identify the right diseases to treat.

Drug development takes a great deal of time, money and effort. While future profits play a big factor in which diseases gets prioritized, advocacy and research incentives can also tilt the scale.

When just one of the thousands of microRNAs in people go awry, it can cause diseases ranging from heart disease to cancer.

Climate finance can help developing countries adapt to climate change and phase out their emissions.

Core-shell structures made of hydrogel could enable more efficient uptake in the body.

Harvard neuroscientist who is unlocking secrets of the canine brain finds skills and temperament are not dictated by breed.

Laboratory findings have set the stage for a clinical trial investigating a drug for pancreatic cancer that has spread to the liver.

Thirteen new graduate student fellows will pursue exciting new paths of knowledge and discovery.

Psychologists have long focused on the importance of a secure attachment with a mother for healthy child development. A new look supports the value of attachment – but it doesn’t have to be with mom.